RA synovial fibroblasts (RASF) analyzed ex vivo from synovial tissue biopsies displayed significantly increased expression of phospho-ribosomal protein S6 (pS6), the major downstream target and effector of the mTOR pathway, in respect to HC (Figure 2A; p = 0.07). This evidence concerns the gene MTOR and rheumatoid arthritis.